e-learning
resources
Munich 2014
Monday, 08.09.2014
Cells, biofilms and biomarkers in respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of bronchoscopic findings and bronchoalveolar lavage (BAL) fluid cytology with regard to BAL fluid microbiology in critically ill patients.
P. Venikos, C. Kampolis, K. Konstantopoulos, A. Armaganides, P. Karakitsos (Athens, Greece)
Source:
International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Session:
Cells, biofilms and biomarkers in respiratory infections
Session type:
Thematic Poster Session
Number:
2505
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Venikos, C. Kampolis, K. Konstantopoulos, A. Armaganides, P. Karakitsos (Athens, Greece). Evaluation of bronchoscopic findings and bronchoalveolar lavage (BAL) fluid cytology with regard to BAL fluid microbiology in critically ill patients.. Eur Respir J 2014; 44: Suppl. 58, 2505
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Lane-hamilton syndrome and CCF: a fatal association
Late Breaking Abstract - The mortality predicting factors at admission and during hospitalisation of pateints with SARS COV2
Related content which might interest you:
Utility and cost of routine bronchoalveolar lavage in diagnosing pulmonary fungal infections
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013
Which BAL fluid (BALF) analyses are clinically useful in immunocomptent children?
Source: Annual Congress 2013 –Paediatric bronchology
Year: 2013
Diagnostic value of pneumocystis-PCR in bronchoalveolar lavage in a clinical setting
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015
Importance of early bronchoalveolar lavage in immunocompromised patients
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Experiences with bronchoalveolar lavage (BAL) in children
Source: Eur Respir J 2004; 24: Suppl. 48, 399s
Year: 2004
Microflora analysis of bronchoalveolar lavage fluids from patients with aspiration pulmonary diseases
Source: Annual Congress 2010 - Mechanisms of respiratory infections
Year: 2010
Comparative study between different methods of aliquots suction during bronchoalveolar lavage
Source: International Congress 2015 – Sedation and educational issues in bronchoscopy: basic bronchoscopic techniques
Year: 2015
Clinical guidelines and indications for bronchoalveolar lavage (BAL)
Source: Guideline 1990
Year: 1990
Diagnostic yield of bronchoalveolar lavage in hematological malignancies
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
Bacterial isolation from broncho-alveolar lavage (BAL) or bronchial lavage fluid
Source: Eur Respir J 2006; 28: Suppl. 50, 735s
Year: 2006
The value of bronchoalveolar lavage in the diagnosis and management of small airway disease
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014
Virological analysis on bronchoalveolar lavage fluid (BALF): Diagnostic yield and indications
Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies
Year: 2011
Microbiological investigation of bronchoalveolar lavage fluid and gastric aspirate in pediatric pulmonary tuberculosis
Source: Annual Congress 2008 - The use of fibreoptic bronchoscopy in children with diffuse or localised lung disease
Year: 2008
Utility of bronchoalveolar lavage in vasculitis patients
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014
Bronchoalveolar lavage amylase levels can be a biomarker of aspiration pneumonia.
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020
LATE-BREAKING ABSTRACT: Molecular diagnostics in the bronchoalveolar lavage in a large cohort of immunocompromised patients
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015
Safety of research bronchoscopy, biopsy and bronchoalveolar lavage in asthma
Source: Eur Respir J 2004; 24: 375-377
Year: 2004
Immunological investigation of bronchoalveolar lavage fluid of sarcoid patients
Source: Eur Respir J 2002; 20: Suppl. 38, 469s
Year: 2002
Bronchoalveolar lavage fluid findings in children with hypersensitivity pneumonitis
Source: Eur Respir J 2003; 21: 144-148
Year: 2003
Bronchoalveolar lavage: how can we use it more effectively to define pathology?
Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept